| 1. |
- Beck, R, et al.
(author)
-
Hyaluronic Acid as an Alternative to Autologous Human Serum Eye Drops: Initial Clinical Results with High-Molecular-Weight Hyaluronic Acid Eye Drops
- 2019
-
In: Case reports in ophthalmology. - : S. Karger AG. - 1663-2699. ; 10:2, s. 244-255
-
Journal article (other academic/artistic)abstract
- <b><i>Introduction:</i></b> Autologous serum eye drops (ASED) are used in the treatment of most severe stages of dry eye. Once introduced, it is currently considered impossible to return to other lubricating eye drops or other commercially available therapeutic regimen. <b><i>Materials and Methods:</i></b> In a randomized study, non-preserved high-molecular-weight hyaluronic acid eye drops were offered as an alternative to 11 patients using autologous serum treatment for at least 3 months. The control group (<i>n</i> = 5) continued their treatment with ASED. The verum group (<i>n</i> = 6) used very-high-molecular-weight hyaluronic eye drops (Comfort Shield®) instead of the ASED. <b><i>Results:</i></b> From four of initially six patients in the verum group that finished the study, 2 (50%) preferred to stay with the very-high-molecular-weight hyaluronic acid eye drops beyond the trial period, the other two returned to the earlier therapy with ASED. The control group continued their treatment as before and finished the study after 8 weeks. <b><i>Conclusion:</i></b> For the first time, artificial eye drops, i.e., high-molecular-weight hyaluronic acid eye drops, offered an acceptable alternative to ASED. Some patients perceived these drops as even better than the patient’s own serum. This is the first evidence that optimization of the molecular structure of hyaluronic acid can be used to create eye drops that are perceived to be better than other tested tear substitutes and even patients’ own serum. This offers a new treatment perspective for patients with very severe dry eye disease.
|
|
